Skip to main content
Journal ArticleOPEN ACCESS

Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn’s disease: Report and systematic literature review of effectiveness and safety

Clinical Case Reports (2020) 8(12) 2874-2877
DOI: 10.1002/ccr3.3090
18Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease.

Author supplied keywords

Cite

CITATION STYLE

APA

Jørgensen, A. H. R., Holm, J. G., & Thomsen, S. F. (2020). Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn’s disease: Report and systematic literature review of effectiveness and safety. Clinical Case Reports, 8(12), 2874–2877. https://doi.org/10.1002/ccr3.3090

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free